Alzheimer's drugs in development in 2019, by clinical trial phase
As of February 2019, over half of the 132 drugs in development for Alzheimer's disease were in the second clinical trial phase. This statistic depicts the amount of Alzheimer's drugs in development as of February 2019, by clinical trial phase.